Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-02-23 Clancy Paul J Executive VP and CFO Shares withheld for taxes −273 $258.99 $71K 26,870
2016-02-23 Clancy Paul J Executive VP and CFO Exercise or conversion · Restricted Stock Unit −579 4,611
2016-02-23 Clancy Paul J Executive VP and CFO Other disposition · Restricted Stock Unit −1,149 3,462
2016-02-23 COVINO GREGORY F VP, Chief Accounting Officer Exercise or conversion +66 2,708.97
2016-02-23 COVINO GREGORY F VP, Chief Accounting Officer Shares withheld for taxes −22 $258.99 $6K 2,686.97
2016-02-23 COVINO GREGORY F VP, Chief Accounting Officer Exercise or conversion · Restricted Stock Unit −66 534
2016-02-23 COVINO GREGORY F VP, Chief Accounting Officer Other disposition · Restricted Stock Unit −132 402
2016-02-23 Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer Exercise or conversion +145 2,597.11
2016-02-23 Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer Shares withheld for taxes −48 $258.99 $12K 2,549.11
2016-02-23 Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −145 1,155
2016-02-23 Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer Other disposition · Restricted Stock Unit −287 868
2016-02-23 ALEXANDER SUSAN H EVP, Chief Legal Officer Exercise or conversion +636 32,140
2016-02-23 ALEXANDER SUSAN H EVP, Chief Legal Officer Shares withheld for taxes −300 $258.99 $78K 31,840
2016-02-23 ALEXANDER SUSAN H EVP, Chief Legal Officer Exercise or conversion · Restricted Stock Unit −636 5,064
2016-02-23 ALEXANDER SUSAN H EVP, Chief Legal Officer Other disposition · Restricted Stock Unit −1,262 3,802
2016-02-23 Cox John EVP Pharmaceutical Oper & Tech Exercise or conversion +810 30,898.39
2016-02-23 Cox John EVP Pharmaceutical Oper & Tech Shares withheld for taxes −382 $258.99 $99K 30,516.39
2016-02-23 Cox John EVP Pharmaceutical Oper & Tech Exercise or conversion · Restricted Stock Unit −810 6,450
2016-02-23 Cox John EVP Pharmaceutical Oper & Tech Other disposition · Restricted Stock Unit −1,608 4,842
2016-02-23 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion +301 1,963.26

Page 71 of 73 · 1,456 trades